Macomics

About:

Macomics is an immuno-oncology company.

Top Investors: Scottish Enterprise, Sun Moritz, Epidarex Capital, Old College Capital, Scottish Investment Bank

Description:

Macomics is an immuno-oncology company. Macomics focus on the development of novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune defence against tumours.

Total Funding Amount:

7.44M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Edinburgh, Edinburgh, City of, United Kingdom

Founded Date:

2020-01-01

Contact Email:

info(AT)macomics.com

Founders:

Coral Ries, Jeffrey Pollard, Luca Cassetta, S. Myatt

Number of Employees:

11-50

Last Funding Date:

2023-01-01

IPO Status:

Private

Industries: